CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions

American Journal of Physiology - Cell Physiology

Volumn 308, Issue 1, 2015, Pages C68-C78

  Shirure, Venktesh S ^a   Liu, Tiantian ^a   Delgadillo, Luis F ^a   Cuckler, Chaz M ^a   Tees, David F J ^b   Benencia, Fabian ^b,c   Goetz, Douglas J ^a,b   Burdick, Monica M ^a,b  

^a Ohio University   (Greece)

^b OHIO UNIVERSITY   (United States)

^c OHIO UNIVERSITY   (United States)

Author keywords

CD44; Cell adhesion; E selectin; Epithelial to mesenchymal Transition; Metastasis

Indexed keywords

CD44V ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITOPE; GLYCAN; SHORT HAIRPIN RNA; 3-GALACTOSYL-N-ACETYLGLUCOSAMINIDE 4-ALPHA-L-FUCOSYLTRANSFERASE; CD44 PROTEIN, HUMAN; FUCOSYLTRANSFERASE; FUT6 PROTEIN, HUMAN; HERMES ANTIGEN; ISOPROTEIN; LIGAND;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE SILENCING; MESENCHYME CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; BLOOD FLOW; BREAST TUMOR; CELL MOTION; CHO CELL LINE; CRICETULUS; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHO CELLS; CRICETULUS; E-SELECTIN; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FUCOSYLTRANSFERASES; GLYCOSYLATION; HUMANS; LIGANDS; NEOPLASM METASTASIS; PHENOTYPE; PROTEIN ISOFORMS; REGIONAL BLOOD FLOW; RNA INTERFERENCE; TRANSFECTION;

EID: 84920895618     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00094.2014     Document Type: Article

References (57)

1. ‑/low breast cancer cellular model MDA-MB-468. BMC Cancer 10: 78, 2010
2. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11: R46, 2009
3. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 23: 7274–7282, 2004
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988, 2003
5. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9: 997–1007, 2011
6. Barthel SR, Gavino JD, Descheny L, Dimitroff CJ. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11: 1473–1491, 2007
7. Barthel SR, Gavino JD, Wiese GK, Jaynes JM, Siddiqui J, Dimitroff CJ. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology 18: 806–817, 2008
8. Barthel SR, Wiese GK, Cho J, Opperman MJ, Hays DL, Siddiqui J, Pienta KJ, Furie B, Dimitroff CJ. α-(1,3)-Fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci USA 106: 19491–19496, 2009
9. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15: 261–273, 2010
10. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121: 1064–1074, 2011
11. Burdick MM, Bochner BS, Collins BE, Schnaar RL, Konstantopoulos K. Glycolipids support E-selectin-specific strong cell tethering under flow. Biochem Biophys Res Commun 284: 42–49, 2001
12. Burdick MM, Chu JT, Godar S, Sackstein R. HCELL is the major Eand L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281: 13899–13905, 2006
13. Burdick MM, Henson KA, Delgadillo LF, Choi YE, Goetz DJ, Tees DF, Benencia F. Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways? Front Oncol 2: 103, 2012
14. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 284: C977–C987, 2003
15. Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, Konstantopoulos K. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J 26: 2648–2656, 2012
16. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64: 5261–5269, 2004
17. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci USA 97: 13841–13846, 2000
18. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 153: 1277–1286, 2001
19. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 64: 5702–5711, 2004
20. Fidler IJ. The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer 3: 453–458, 2003
21. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, Hasegawa A, Asa D, Brandley BK. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol 117: 895–902, 1992
22. + human T cells. Blood 107: 1421–1426, 2006
23. Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 92: 3038–3044, 1993
24. Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 65: 5812–5817, 2005
25. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J 20: 337–339, 2006
26. Jacobs PP, Sackstein R. CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett 585: 3148–3158, 2011
27. Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res 13: R59, 2011
28. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420–1428, 2009
29. Kannagi R, Hakomori S. A guide to monoclonal antibodies directed to glycotopes. Adv Exp Med Biol 491: 587–630, 2001
30. Konstantopoulos K, Thomas SN. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 11: 177–202, 2009
31. Krause T, Turner GA. Are selectins involved in metastasis? Clin Exp Metastasis 17: 183–192, 1999
32. Kummitha CM, Shirure VS, Delgadillo LF, Deosarkar SP, Tees DF, Burdick MM, Goetz DJ. HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions. J Immunol Methods 384: 43–50, 2012
33. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres- Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645–648, 1994
34. Lesley J, Hyman R, English N, Catterall JB, Turner GA. CD44 in inflammation and metastasis. Glycoconjugate J 14: 611–622, 1997
35. Liu S, Clouthier SG, Wicha MS. Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 17: 15–21, 2012
36. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704–715, 2008
37. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 188: 465–474, 1998
38. Olsson E, Honeth G, Bendahl PO, Saal LH, Gruvberger-Saal S, Ringner M, Vallon-Christersson J, Jonsson G, Holm K, Lovgren K, Ferno M, Grabau D, Borg A, Hegardt C. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 11: 418, 2011
39. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645–3654, 2008
40. Osterbur J, Sprague L, Muccioli M, Pate M, Mansfield K, McGinty J, Li Y, Li Y, Shirure V, Courreges MC, Benencia F. Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. Immunobiology 218: 64–75, 2013
41. Sackstein R. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration. Ann Biomed Eng 40: 766–776, 2012
42. Sackstein R, Dimitroff CJ. A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood 96: 2765–2774, 2000
43. Sakuma K, Aoki M, Kannagi R. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 109: 7776–7781, 2012
44. Schweitzer KM, Drager AM, van der Valk P, Thijsen SF, Zevenbergen A, Theijsmeijer AP, van der Schoot CE, Langenhuijsen MM. Constitutive expression of E-selectin and vascular cell adhesion molecule- 1 on endothelial cells of hematopoietic tissues. Am J Pathol 148: 165–175, 1996
45. -breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8: R59, 2006
46. Shirure VS, Henson KA, Schnaar RL, Nimrichter L, Burdick MM. Gangliosides expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun 406: 423–429, 2011
47. Shirure VS, Reynolds NM, Burdick MM. Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells. PLos One 7: 44529, 2012
48. Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K, Hasegawa A, Kannagi R. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 179: 713–719, 1991
49. Takeo K, Kawai T, Nishida K, Masuda K, Teshima-Kondo S, Tanahashi T, Rokutan K. Oxidative stress-induced alternative splicing of transformer 2β (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells. Am J Physiol Cell Physiol 297: C330–C338, 2009
50. Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D, Georgoulias V. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288: 99–106, 2010
51. Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 283: 15647–15655, 2008
52. Tyrrell D, James P, Rao N, Foxall C, Abbas S, Dasgupta F, Nashed M, Hasegawa A, Kiso M, Asa D, et al. Structural requirements for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci USA 88: 10372– 10376, 1991
53. Wagers AJ, Lowe JB, Kansas GS. An important role for the α1,3- fucosyltransferase, FucT-VII, in leukocyte adhesion to E-selectin. Blood 88: 2125–2132, 1996
54. Wagers AJ, Stoolman LM, Craig R, Knibbs RN, Kansas GS. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins. J Immunol 160: 5122–5129, 1998
55. Weiss L, Haydock K, Pickren JW, Lane WW. Organ vascularity and metastatic frequency. Am J Pathol 101: 101–113, 1980
56. Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, Guise TA. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA 100: 10954–10959, 2003
57. Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY, Liu Y. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLos One 3: 1826, 2008.